Tag Archives: agent

New anti-VEGF agent could reduce treatment burden for patients with wet AMD


Novartis proprietary anti-VEGF agent RTH258 (brolucizumab) appears to be noninferior to aflibercept for treatment of neovascular age-related macular degeneration (AMD), according to results from 2 ongoing phase 3 studies.[Read More ] Source: Daily Dose of Eye Care
https://www.lvcenter4sight.com/new-anti-vegf-agent-could-reduce-treatment-burden-for-patients-with-wet-amd/